Jul 27, 2026Effective9999999995-26-002465
All companies
Trade Propanc Biopharma Inc
PR
Propanc Biopharma Inc
PPCBPublicArchived
Public / ArchivedUnited States(Nasdaq)Best valuation $4.73M1 market
Public listing
Listed· Nasdaq· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available
Sources: sec-harvest, sec-edgar, nasdaq
IPO Calendar · NasdaqIPO
PPCBPrice
$1.35
24h
-39.46%
Valuation
$4.73M
24h volume
$5.48M
Type
IPO
Trade Propanc Biopharma IncNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 2h ago
Financials
UnprofitableFrom SEC filings, latest FY ending Jun 30, 2025 · CIK 0001517681.
Revenue
—
Net income
-$58.92M
Gross margin
—
Cash
$4.07K
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating income | -$57.28M | -$1.54M | -$1.78M | -$1.99M | -$1.81M |
| Net income | -$58.92M | -$1.82M | -$2.66M | -$2.66M | -$2.03M |
| R&D expense | $223.72K | $248.1K | $247.92K | $256.05K | $230.96K |
| Cash & equivalents | — | — | — | $4.07K | $2.26K |
| Total assets | $19.63M | $72.37K | $60.33K | $81.65K | $13.1K |
| Total liabilities | $5.73M | $3.85M | $3.18M | $3.11M | $3.08M |
| Shareholders' equity | $13.91M | -$3.78M | -$3.12M | -$3.02M | -$3.07M |
SEC IPO filings
EffectiveEDGAR filings resolved from PPCB / CIK 0001517681.
S-1S-1
Jul 17, 2026Filed0001493152-26-033807
Apr 20, 2026Effective9999999995-26-001258
CORRESPfilename1.htm
Apr 16, 2026SEC correspondence0001493152-26-017000
UPLOADfilename1.pdf
Apr 15, 2026SEC correspondence0000000000-26-003828
S-1S-1
Apr 10, 2026Filed0001493152-26-016228
424B3424B3
Mar 6, 2026Final prospectus0001493152-26-009199
Feb 24, 2026Effective9999999995-26-000658
CORRESPfilename1.htm
Feb 20, 2026SEC correspondence0001493152-26-007520
S-1/AS-1/A
Feb 19, 2026Amended0001493152-26-007492
CORRESPfilename1.htm
Feb 12, 2026SEC correspondence0001493152-26-006497
CORRESPfilename1.htm
Feb 10, 2026SEC correspondence0001493152-26-006023
Propanc Biopharma Inc IPO — frequently asked questions
- When did Propanc Biopharma Inc go public?
- Propanc Biopharma Inc has already gone public and now trades publicly on Nasdaq under the ticker PPCB.
- Can I buy Propanc Biopharma Inc stock?
- Yes — Propanc Biopharma Inc is publicly traded on Nasdaq as PPCB. You can follow its live price, valuation and post-IPO performance above.
- What is Propanc Biopharma Inc's valuation?
- Propanc Biopharma Inc's most recent valuation tracked here is $4.73M, derived from live market prices.